be visible on the BioBusiness market ISSN 2300-0228

Log in | Register

Pivotal announces participation in two clinical trials with a novel investigational immunotherapy drug to treat melanoma and lung cancer
Impressions from the visit to Wageningen, the specter of famine, CRISPR Cas9 to the rescue!
Reach out to potential partners and customers in the Danish-Swedish life science cluster, Medicon Valley
Central European Healthcare Expo (20-21.05.2020 Global Expo Warsaw)
The world of healthcare ...

All articles

Filters:

Show search box

2015-10-19

Vaccine against AIDS in Phase I clinical trials

Vaccine against AIDS in Phase I clinical trials

A vaccine based on HIV gp120 protein is a unique product for 15 years protection against infection. Unique, because it has been introduced by the team of Prof. Robert Gallo – a pioneer in the field of AIDS research and previous critic of disease-related vaccination.... Read more

Tags clinical trials , HIV , vaccine , AIDS , gp120